Pakistan is gearing up to receive 200,000 doses of Pfizer’s latest Covid-19 vaccine from the United States, with expectations of their arrival in the coming days. Furthermore, an additional 300,000 doses of the Pfizer vaccine are anticipated to reach the country within the same month.
The Pfizer vaccine, known for its efficacy, comes at a crucial time as it has demonstrated effectiveness against a new variant of Covid-19, denoted as JN1. This variant has been rapidly spreading in various countries, including America, Britain, and India. Fortunately, no cases of the JN1 variant have been reported in Pakistan thus far.
With the current positivity ratio of Covid-19 cases in Pakistan standing at less than one percent, the arrival of the new vaccine brings a ray of hope to the nation. The vaccine is strategically planned to be administered primarily to pilgrims and individuals identified as high-risk, contributing to the country’s ongoing efforts to mitigate the spread of the virus.
As the global fight against the pandemic continues, this timely acquisition of Pfizer’s new Covid-19 vaccine marks a positive step for Pakistan in its commitment to safeguarding public health and preventing the potential impact of emerging variants.
